Pinterest • The world’s catalogue of ideas

Sun Pharmaceuticals Industries Limited has announced that Sun Pharmaceutical Industries Ltd, along with its subsidiary ( Sun Pharma) has entered into a settlement agreement with Acorda Therapeutics, Inc. - See more at:


Sun Pharmaceutical Industries Ltd announced today the successful completion of its acquisition of InSite Vision Incorporated.

Here’s a round-up of the stories thus far: Reuters: FDA bans imports from Sun Pharma plant in India crackdown The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd’s plant at Karkhadi in the western state of Gujarat, in the latest quality blow for India’s drug sector. …

Sun Pharmaceutical Industries Ltd’s southward journey continues for yet another trading session. The scrip is currently trading 1.3% lower at Rs. 709.15 on BSE, which is a 16-month low level. - See more at:

Sun Pharma: The US drug regulator has found seven breaches of manufacturing standards at Sun Pharmaceutical Industries Ltd’s formulations plant in Mohali, Punjab, following a recent inspection.

Sun Pharmaceutical Industries Ltd posted a net profit of Rs. 17136.90 million for the quarter ended March 31, 2016 where as the same was at Rs. 8892.40 - See more at:

Shares of Sun Pharmaceutical Industries Ltd are currently trading 1.50% higher at Rs. 770.35 on BSE after it was reported by a financial daily that the company will raise Rs. 1,000 crore from the domestic bond market via its arm Sun Laboratories.

Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 849, up by 8.6 points or 1.02% from its previous closing of Rs. 839.7 - See more at:


Sun Pharmaceuticals Industries Ltd is currently trading at Rs. 913, up by 1.7% from its previous closing of Rs. 898.2 on the BSE. - See more at: